Post by AI-Driven Therapeutics

One of the best parts of building a biotech startup is reconnecting with the people and communities that inspired you in the first place. We were delighted to welcome Hope Woods and Rachel Clune, Ph.D. from the Rosetta Commons and discuss science, software, AI, and the future of protein design. Long before AlphaFold, ProteinMPNN, and generative protein design became household names in our field, many of us learned protein modeling through Rosetta. It was our gateway into structural biology and ultimately one of the reasons AI-Driven Therapeutics exists today. Thank you for the visit and the thoughtful exchange.